Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 12 images provide visual information about the product associated with Gabapentin NDC 0228-2636 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image 1

image 1

This is a formula for calculating estimated creatinine clearance rate (cLcr) based on age, weight, and serum creatinine levels. The formula is adjusted for female patients by multiplying the result by 0.85.*

image 10

image 10

image 11

image 11

This is a medication description for Gabapentin tablets, USP that contains 600mg of Gabapentin, manufactured by Watson Pharma Private Limited in India for Teva Pharmaceuticals. The medication guide provided by the pharmacist should be given to each patient. The tablets are available in 100s and should be kept in a light-resistant container. The dosage can be found in the accompanying circular for full prescribing information. The medication should be stored at room temperature and kept away from children. The code number for the drug is GO/DRUGS/741 while the serialization coding area is 52-0267. A link to print medication guides for this drug is also provided on tevausa.com/medguides.*

image 12

image 12

This is a medication guide for Gabapentin tablets containing 800mg of the drug per tablet. The medication is dispensed in a container that is tight and light-resistant as per the USP. The circular accompanying the medication gives full prescribing information including the usual dosage. The medication should be kept out of reach of children and stored at 25°C with excursions permitted to 15° to 30°C. The medication is manufactured in India by Watson Pharma Private Limited and is sold by Teva Pharmaceuticals. There is a serialization coding area on the packaging with the code 0228-2637-11. Print Medication Guides are available at www.tevausa.com/medguides.*

image 2

image 2

image 3

image 3

image 4

image 4

image 5

image 5

This is a chart representing the Mean Pain Score over a 4-week dose titration period and a subsequent 8-week fixed dose period. The chart includes a placebo control group and a group taking Gabapentin at a dosage of 3600 mg/day. The chart provides data points for eight weeks, labeled as Baseline, 1, 2, 3, 4, 5, 6, 7, and 8.*

image 6

image 6

image 7

image 7

image 8

image 8

image 9

image 9

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.